Analyst
Jefferies
Equibles does not estimate personal net worth.
Dhaval Khur is recorded as Analyst at Jefferies. Dhaval Khur has spoken on 1 earnings call across 1 company, most recently for Piramal Pharma Limited on October 28, 2026. The companies whose calls Dhaval Khur spoke on are classified in the Healthcare sector.
“Can you inform us about what is the current business mix at Lexington? Is it more clinical or commercial, small molecule versus biologics and ADC?”
Jefferies
Analyst
Transcript header (unverified)
Piramal Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Piramal Pharma Limited
